414 related articles for article (PubMed ID: 26423196)
1. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
[TBL] [Abstract][Full Text] [Related]
2. Cord blood transplantation for cure of HIV infections.
Petz L
Stem Cells Transl Med; 2013 Sep; 2(9):635-7. PubMed ID: 23884642
[TBL] [Abstract][Full Text] [Related]
3. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.
Gupta RK; Peppa D; Hill AL; Gálvez C; Salgado M; Pace M; McCoy LE; Griffith SA; Thornhill J; Alrubayyi A; Huyveneers LEP; Nastouli E; Grant P; Edwards SG; Innes AJ; Frater J; Nijhuis M; Wensing AMJ; Martinez-Picado J; Olavarria E
Lancet HIV; 2020 May; 7(5):e340-e347. PubMed ID: 32169158
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Gupta RK; Abdul-Jawad S; McCoy LE; Mok HP; Peppa D; Salgado M; Martinez-Picado J; Nijhuis M; Wensing AMJ; Lee H; Grant P; Nastouli E; Lambert J; Pace M; Salasc F; Monit C; Innes AJ; Muir L; Waters L; Frater J; Lever AML; Edwards SG; Gabriel IH; Olavarria E
Nature; 2019 Apr; 568(7751):244-248. PubMed ID: 30836379
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell transplantation with cord blood for cure of HIV infections.
Petz LD; Redei I; Bryson Y; Regan D; Kurtzberg J; Shpall E; Gutman J; Querol S; Clark P; Tonai R; Santos S; Bravo A; Spellman S; Gragert L; Rossi J; Li S; Li H; Senitzer D; Zaia J; Rosenthal J; Forman S; Chow R
Biol Blood Marrow Transplant; 2013 Mar; 19(3):393-7. PubMed ID: 23089564
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CCR5
Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
[TBL] [Abstract][Full Text] [Related]
7. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
Hütter G; Nowak D; Mossner M; Ganepola S; Müssig A; Allers K; Schneider T; Hofmann J; Kücherer C; Blau O; Blau IW; Hofmann WK; Thiel E
N Engl J Med; 2009 Feb; 360(7):692-8. PubMed ID: 19213682
[TBL] [Abstract][Full Text] [Related]
8. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
[TBL] [Abstract][Full Text] [Related]
9. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
10. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.
Henrich TJ; Hanhauser E; Hu Z; Stellbrink HJ; Noah C; Martin JN; Deeks SG; Kuritzkes DR; Pereyra F
AIDS; 2015 May; 29(8):867-76. PubMed ID: 25730507
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
Salgado M; Kwon M; Gálvez C; Badiola J; Nijhuis M; Bandera A; Balsalobre P; Miralles P; Buño I; Martinez-Laperche C; Vilaplana C; Jurado M; Clotet B; Wensing A; Martinez-Picado J; Diez-Martin JL;
Ann Intern Med; 2018 Nov; 169(10):674-683. PubMed ID: 30326031
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
Hsu J; Van Besien K; Glesby MJ; Pahwa S; Coletti A; Warshaw MG; Petz L; Moore TB; Chen YH; Pallikkuth S; Dhummakupt A; Cortado R; Golner A; Bone F; Baldo M; Riches M; Mellors JW; Tobin NH; Browning R; Persaud D; Bryson Y;
Cell; 2023 Mar; 186(6):1115-1126.e8. PubMed ID: 36931242
[TBL] [Abstract][Full Text] [Related]
13. HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.
Ballana E; Riveira-Munoz E; Pou C; Bach V; Parera M; Noguera M; Santos JR; Badia R; Casadellà M; Clotet B; Paredes R; Martínez MA; Brander C; Esté JA
Immunobiology; 2013 Apr; 218(4):543-7. PubMed ID: 22818666
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
[TBL] [Abstract][Full Text] [Related]
15. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
Allers K; Schneider T
Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
[TBL] [Abstract][Full Text] [Related]
16. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA; Kang S; Koup RA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
[TBL] [Abstract][Full Text] [Related]
17. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
18. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Allers K; Hütter G; Hofmann J; Loddenkemper C; Rieger K; Thiel E; Schneider T
Blood; 2011 Mar; 117(10):2791-9. PubMed ID: 21148083
[TBL] [Abstract][Full Text] [Related]
20. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
